carnitine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakaya, H; Tohse, N | 1 |
Amico-Roxas, M; Caruso, A; Cutuli, VM; De Bernardis, E; Leonardi, G | 1 |
Akisü, M; Coker, I; Hüseyinov, A; Kültürsay, N | 1 |
Battaglia, C; Brevetti, G; Gentile, M; Golino, P; Marone, G; Oriente, A; Triggiani, M | 1 |
1 trial(s) available for carnitine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine.
Topics: Adult; Arachidonic Acids; Blood Platelets; Cardiotonic Agents; Carnitine; Eicosanoids; Humans; In Vitro Techniques; Ischemia; Male; Middle Aged; Neutrophils; Platelet Activating Factor | 1999 |
3 other study(ies) available for carnitine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine.
Topics: Action Potentials; Animals; Carnitine; Dogs; Female; Heart; In Vitro Techniques; Lysophosphatidylcholines; Male; Membrane Potentials; Myocardial Contraction; Papillary Muscles; Platelet Activating Factor; Purkinje Fibers | 1986 |
Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
Topics: Animals; Cardiotonic Agents; Carnitine; Carrageenan; Dose-Response Relationship, Drug; Edema; Indomethacin; Male; Phenylbutazone; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury.
Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Carnitine; Female; Hypoxia; Male; Osmolar Concentration; Platelet Activating Factor; Rats; Rats, Wistar | 1998 |